3D Printing Medical Device Market
3D Printing Medical Device Market Study by 3D Printers, 3D Bio-printers, Material, and Software & Services for Surgical Guides & Instruments, Prosthetics & Implants, and Others from 2024 to 2034
Analysis of 3D Printing Medical Device Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
3D Printing Medical Device Market Outlook (2024 to 2034)
Growing demand for customized medical devices key factor driving global 3D printing medical device market growth. Worldwide sales of 3D printing medical devices are estimated at US$ 3.76 billion in 2024 and projected to reach US$ 13.79 billion by 2034, increasing at a CAGR of 13.9% from 2024 to 2034.
Increasing manufacturing of various advanced surgical tools in the healthcare sector is anticipated to contribute to the rising demand for 3D printing medical devices. In addition, growing awareness and constant technological advancements in 3D printing medical devices are also contributing to market progress. Manufacturers in the medical industry are utilizing 3D printing technology for prototyping novel device designs to enable quick refinement and iteration, therefore contributing to the development of rapid and more effective devices.
More manufacturers specializing in the production of advanced 3D printing medical devices are emphasizing customization. They are working in close collaboration with healthcare professionals for the development of devices matching unique anatomies of respective patients, thus ensuring enhanced functionality and better fit. The expansion of healthcare facilities in potentially high-growth countries is leading to the development of high-value 3D printing medical devices, which is generating lucrative opportunities for players.
- Sales of 3D printing medical devices in South Korea are projected to rise at a CAGR of 14.5% from 2024 to 2034.
- North America is forecasted to account for 35.2% of the global 3D printing medical device market share by 2034-end.
- Demand for 3D printers is projected to accelerate at 15% CAGR and reach a market value of US$ 5.81 billion by the end of 2034.
Several benefits associated with the use of 3D printing medical devices, including improved patient outcomes, reduced reproduction time, and customization features are estimated to contribute to their rising sales. Further, an increasing requirement for 3D-printed surgical instruments is projected to generate lucrative opportunities for players.
Report Attributes | Details |
---|---|
3D Printing Medical Device Market Size (2024E) | US$ 3.76 Billion |
Forecasted Market Value (2034F) | US$ 13.79 Billion |
Global Market Growth Rate (2024 to 2034) | 13.9% CAGR |
Market Share of Laser Beam Technology Segment (2034F) | 30.6% |
Japan Market Growth Rate (2024 to 2034) | 5.2% CAGR |
South Asia & Pacific Market Share (2034F) | 22.7% |
Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Factors are Responsible for Rising Demand for 3D Printing Medical Devices?
“Transformation in Use of Medical Devices”
3D printing technology helps transform the use of medical devices for the treatment of patients in the healthcare sector. The technology helps build implantable and non-implantable medical devices, which are adopted as cost-effective solutions. With the use of medical devices surgeons can plan their surgeries while minimizing the risks associated with complex medical procedures, subsequently maximizing success rate. It is also leading to minimizing the chances associated with infection and reducing the duration of anesthesia exposure. These features ultimately contribute to the faster recovery of patients.
Testing of organs is estimated to become more convenient with the use of 3D printing technology, which assists in revolutionizing drug testing, therefore offering an efficient alternative to animal testing.
Which Challenges are Limiting Prospects for Suppliers of 3D Printing Medical Devices?
“Socio-ethical Concerns Related to Utilization of 3D Printed Products”
3D printing is utilized in the development of products, which find application in the medical sector. It is used in the development of organs and tissues to cater to the specific requirements of organ transplantation. Biomaterials and living cells are utilized in 3D printing procedures for developing human organs. However, the use of these 3D-printed products in the human body is leading to biosafety concerns, which ultimately raises ethical issues. Certain regions are against living cells' use in medicine.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How are New Companies Expected to Fare the Global Market Landscape?
“Investments in Developing High Precision Technology”
The evolution of 3D printing is dependent on the size and requirements of healthcare facilities. High-throughput 3D printers provide good quality solutions2 for large healthcare facilities, which are required for the production of appliances regularly. CAM (computer-aided manufacturing) and CAD (computer-aided design) are embraced in the dental and medical industries for their high precision. Startups are expected to invest in the development of versatile 3D printers for multiple practices, which leads to their adoption in hospitals and dental clinics.
Country-wise Insights
North America is anticipated to contribute 35.2% share of the global market by 2034-end, as revealed in the research analysis published by Fact.MR, a market research and competitive intelligence provider. The presence of well-established healthcare facilities, including hospitals, diagnostic centers, etc. is leading to the installation of 3D printers in respective facilities to offer more effective services.
Why Should Market Players Invest in the United States?
“Presence of Well-established Healthcare Infrastructure Widening Application Scope of 3D Printing Medical Devices”
Attribute | United States |
---|---|
Market Value (2024E) | US$ 1.23 Billion |
Growth Rate (2024 to 2034) | 15% CAGR |
Projected Value (2034F) | US$ 4.95 Billion |
The United States is forecasted to enjoy a share of 81.4% of the North American market by the end of 2034. Increasing production of 3D printed wearables to match the increasing demand of respective end users is contributing to expanding the 3D printing medical device market size in the country. Rising expenditure on R&D activities conducted on 3D printing technology is estimated to contribute to market dynamics. In addition, the presence of research centers, universities, and medical institutions in the country is also leading to the active use of 3D printing technology for developing novel medical products, creating patient-specific implants, and surgical planning.
Which Key 3D Printing Medical Device Market Trends are Prevalent in China?
“High Spending by Companies Fueling Growth Opportunities”
Attribute | China |
---|---|
Market Value (2024E) | US$ 302.2 Million |
Growth Rate (2024 to 2034) | 18.6% CAGR |
Projected Value (2034F) | US$ 1.66 Billion |
China is approximated to account for 64.9% share of the East Asian market by 2034-end. Increasing demand for more effective healthcare services along with rising requirements for medical devices are driving opportunities for 3D printing medical device suppliers. Further, the growing concentration of market players in the country as one of the key locations for sourcing and manufacturing is driving market growth.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Global demand for 3D printers is approximated to increase at a CAGR of 15% and reach a value of US$ 5.81 billion by 2034-end, as slated in Fact.MR report. This rising demand is due to the growing requirements for advanced manufacturing technologies, the ability to achieve high-quality output, and the need for customized and complex parts.
Why are Laser-beam Technology-based 3D Printing Medical Devices Gaining Prominence?
“Wide Application of 3D Printing in Dentistry and Preference to Minimally Invasive Surgeries”
Attribute | Laser Beam |
---|---|
Segment Value (2024E) | US$ 1.05 Billion |
Growth Rate (2024 to 2034) | 14.9% CAGR |
Projected Value (2034F) | US$ 4.22 Billion |
Laser beam technology-based 3D printing medical devices are anticipated to hold 30.6% share of the global market by the end of the assessment period in 2034. Rising demand for these technology-based medical devices is owing to the extensive application of 3D printing in dentistry. Moreover, an increase in the production of implants for use in minimally invasive surgery is also contributing to the adoption of 3D printing medical devices.
Which End User Accounts for High Revenue Streams?
“High Demand for Fabricated/Personalized Healthcare Solutions in Hospitals”
Attribute | Hospitals |
---|---|
Segment Value (2024E) | US$ 2.12 Billion |
Growth Rate (2024 to 2034) | 14% CAGR |
Projected Value (2034F) | US$ 7.84 Billion |
Hospitals are calculated to contribute 56.9% share of global market revenue by the end of 2034. Increased demand for 3D printing medical devices in these healthcare settings is attributed to the growing count of 3D printing laboratories and the emphasis on outsourcing various manufacturing functions. In addition, rising requirements for fabricated/personalized solutions are also driving demand for 3D printing medical devices in hospitals.
Competitive Landscape
The global market is highly competitive and fragmented with the presence of multiple regional as well as domestic players. New product development, offering quality products, and management of supply chain systems are some key initiatives taken by players. Numerous marketing strategies have also been adopted by prominent players, including collaborations, mergers & acquisitions, partnerships, and expansion to upscale their market presence.
For instance :
- Stratasys Ltd. come up with J5 DentaJet 3D Poly Jet printer in March 2021. This was designed for use in dental laboratories.
- SLM Solutions entered into a partnership with Canwell Medical in 2020. This partnership is estimated to enable Canwell Medical to utilize SLM machines for the production of 3D-printed surgical implant instruments.
Key players in the 3D printing medical device market are 3D Systems Corporation, Cyfuse Biomedical K.K., Biomedical Modeling Inc., Stratasys Ltd., Carbon, Inc., SLM Solutions Group AG, Renishaw Plc, General Electric Company, Organovo Holdings, Inc., Envision TEC GmbH, Groupe Gorge SA, and Materialise NV.
Segmentation of 3D Printing Medical Device Market Research
-
By Product :
- 3D Printers
- 3D Bio-printers
- Material
- Software & Services
-
By Technology :
- Laser Beam Melting
- Photo Polymerization
- Three-dimensional Printing
- Electron Beam Melting
- Droplet Deposition
-
By Application :
- Surgical Guides
- Surgical Instruments
- Standard Prosthetics & Implants
- Tissue-engineered Products
- Hearing Aids
- External Wearable Devices
-
By End User :
- Hospitals
- Academic Institutes
- Contract Research Organizations
- Pharma & Biotech Companies
-
By Region :
- North America
- Europe
- East Asia
- Latin America
- Middle East & Africa
- South Asia & Oceania
- FAQs -
What is the 3D printing medical device market size in 2024?
The global 3D printing medical device market is estimated at US$ 3.76 billion in 2024.
What is the demand projection for 3D printing medical devices for 2034?
Worldwide demand for 3D printing medical devices is anticipated to reach a market valuation of US$ 13.79 billion by 2034.
What is the projected growth rate for the global market?
The global market is forecasted to expand at 13.9% CAGR from 2024 to 2034.
What is the contribution of North America to global market revenue?
North America is evaluated to hold 35.2% share of the global market by the end of 2034.
What is the forecasted growth for the South Korean market?
Sales of 3D printing medical devices in South Korea are approximated to rise at a 14.5% CAGR from 2024 to 2034.
How much share of the global market will 3D printers hold by 2034?
3D printers are expected to account for 42.1% of global market revenue share by 2034.